CLN.WA Forward P/E

The Forward P/E of Celon Pharma SA (CLN.WA) is 147.06.

Forward P/E estimates how much investors are willing to pay today for each dollar of a company's expected future earnings. It serves as a valuation tool based on projected profitability rather than past performance.

CLN.WA Forward P/E - Peers Comparison

Ticker	Name	Value
PHO.OL	Photocure ASA	34.86
PRL.MI	Pierrel SpA	142.57
SHE.MI	Shedir Pharma Srl Unipersonale	8.70
CALTX.ST	Calliditas Therapeutics AB	89.64
CLBIO.ST	Corline Biomedical AB	18.44
EAH.L	ECO Animal Health Group PLC	3964.84
SECARE.ST	Swedencare AB (publ)	29.20
OAT.WA	Oncoarendi Therapeutics SA	0.54